287 related articles for article (PubMed ID: 11502705)
1. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
Wathen MS; Sweeney MO; DeGroot PJ; Stark AJ; Koehler JL; Chisner MB; Machado C; Adkisson WO;
Circulation; 2001 Aug; 104(7):796-801. PubMed ID: 11502705
[TBL] [Abstract][Full Text] [Related]
2. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
4. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
[TBL] [Abstract][Full Text] [Related]
5. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial.
Gasparini M; Anselme F; Clementy J; Santini M; Martínez-Ferrer J; De Santo T; Santi E; Schwab JO;
Am Heart J; 2010 Jun; 159(6):1116-1123.e2. PubMed ID: 20569728
[TBL] [Abstract][Full Text] [Related]
6. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
[TBL] [Abstract][Full Text] [Related]
7. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
Grimm W; Plachta E; Maisch B
Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
[TBL] [Abstract][Full Text] [Related]
8. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
[TBL] [Abstract][Full Text] [Related]
9. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
Joung B; Lexcen DR; Ching CK; Silver MT; Piccini JP; Sterns LD; Rabinovich R; Pickett RA; Liu S; Brown ML; Cheng A
Heart Rhythm; 2020 Jan; 17(1):98-105. PubMed ID: 31369873
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study.
Martins RP; Blangy H; Muresan L; Freysz L; Groben L; Zinzius PY; Schwartz J; Sellal JM; Aliot E; Sadoul N
Europace; 2012 Oct; 14(10):1457-64. PubMed ID: 22547765
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study.
Jiménez-Candil J; Anguera I; Durán O; Hernández J; Fernández-Portales J; Moríñigo JL; Martín A; Dallaglio P; Bravo L; di Marco A; Sánchez PL
J Interv Card Electrophysiol; 2018 Jun; 52(1):69-76. PubMed ID: 29557531
[TBL] [Abstract][Full Text] [Related]
12. Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality.
Landolina M; Lunati M; Boriani G; Pietro Ricci R; Proclemer A; Facchin D; Rordorf R; Morani G; Maines M; Gasparini G; Molon G; Turrini P; Gasparini M;
Heart Rhythm; 2016 Feb; 13(2):472-80. PubMed ID: 26477710
[TBL] [Abstract][Full Text] [Related]
13. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of anti-tachycardia pacing for terminating fast ventricular tachycardia in Japanese implantable cardioverter defibrillator patients. Primary results of the SATISFACTION study.
Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Okuyama Y; Mizuno H; Shimoshige S; Takenaka S; Sumiyoshi T; Yambe Y; Shirota K; Nitta J; Ito M; Keida T; Nanto S
Circ J; 2014; 78(11):2643-50. PubMed ID: 25262963
[TBL] [Abstract][Full Text] [Related]
15. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
[TBL] [Abstract][Full Text] [Related]
16. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
[TBL] [Abstract][Full Text] [Related]
18. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
Sweeney MO; Sherfesee L; DeGroot PJ; Wathen MS; Wilkoff BL
Heart Rhythm; 2010 Mar; 7(3):353-60. PubMed ID: 20185109
[TBL] [Abstract][Full Text] [Related]
19. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.
Wathen M
Am Heart J; 2007 Apr; 153(4 Suppl):44-52. PubMed ID: 17394902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
